Abstract
Cancer cells often resist Fas-mediated apoptosis even when the Fas receptor is expressed at the cell surface. We show here that human and rat colon cancer cells undergo massive apoptosis when they are exposed to soluble Fas ligand in the presence of sodium butyrate, an agent that induces by itself only a low rate of apoptosis. Sodium butyrate potentiates Fas-dependent apoptosis in seven out of eight colon cancer cell lines. Sodium butyrate does not increase Fas receptor cell surface expression and does not modify cell levels of Bcl-2, Bcl-xL, Bcl-xS and Bax. Sodium butyrate also induces tumor cell sensitization to the apoptotic effect of the combination of TNF-α and IFN-γ, but it does not modify the level of the FADD/Mort1 adaptator molecule, at the connection between Fas- and TNF-dependent apoptosis pathways. Because the clinical toxicity of butyrate is low, its ability to enhance Fas-signal delivery in cancer cells could be of therapeutic interest.
Article PDF
Author information
Authors and Affiliations
Additional information
Edited by M. Piacentini
Rights and permissions
About this article
Cite this article
Bonnotte, B., Favre, N., Reveneau, S. et al. Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate. Cell Death Differ 5, 480–487 (1998). https://doi.org/10.1038/sj.cdd.4400371
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400371
Keywords
This article is cited by
-
The fermented non-digestible fraction of common bean (Phaseolus vulgaris L.) triggers cell cycle arrest and apoptosis in human colon adenocarcinoma cells
Genes & Nutrition (2014)
-
Sodium butyrate induced keratinocyte apoptosis
Apoptosis (2006)
-
Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP
Cell Death & Differentiation (2005)
-
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines
Investigational New Drugs (2005)
-
The HIV protease inhibitor ritonavir synergizes with butyrate for induction of apoptotic cell death and mediates expression of heme oxygenase‐1 in DLD‐1 colon carcinoma cells
British Journal of Pharmacology (2004)